Cytek earnings
WebApr 13, 2024 · Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) CEO Wenbin Jiang sold 20,000 shares of Cytek Biosciences stock in a transaction that occurred on Monday, April 10th.The stock was sold at an average price of $8.88, for a total transaction of $177,600.00. Following the sale, the chief executive officer now owns 7,684,439 shares … WebFeb 28, 2024 · Cytek Biosciences, Inc. provided earnings guidance for the full year 2024. For the year, the company expects revenue in the range of $225 million to $235 million, …
Cytek earnings
Did you know?
WebFeb 28, 2024 · Cytek Biosciences, Inc. provided revenue guidance for the full year 2024. For the year, the company expects revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This includes approximately $20 million of revenue contribution from the acquisition of Luminex's Flow Cytometry and … WebCytek Biosciences Reports Second Quarter 2024 Financial Results Earnings Per Share Estimated Reported Quarterly Earnings Surprise Amount Yearly Earnings Forecast Quarterly Earnings...
WebApr 12, 2024 · Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript SA Transcripts Sat, Nov. 12, 2024 Cytek Biosciences, Inc. (CTKB) CEO Wenbin Jiang on Q2 2024 Results Earnings Call Transcript... WebApr 11, 2024 · The Zacks Consensus Estimate for Encompass Health’s 2024 earnings is pegged at $3.07 per share, indicating a 7.7% increase from the prior-year reported figure. The consensus mark for 2024...
WebAug 11, 2024 · Q2: 2024-08-10 Earnings Summary Press Release EPS of $0.03 misses by $0.01 Revenue of $40.16M (32.07% Y/Y) beats by $530.00K Cytek Biosciences, Inc. ( NASDAQ: CTKB) Q2 2024 Earnings... WebFeb 26, 2024 · Cytek Biosciences (NASDAQ:CTKB – Get Rating) is scheduled to release its earnings data after the market closes on Tuesday, February 28th.Analysts expect Cytek Biosciences to post earnings of $0.05 per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.. Cytek Biosciences …
WebApr 12, 2024 · On Tuesday, March 7th, Wenbin Jiang sold 20,000 shares of Cytek Biosciences stock. The shares were sold at an average price of $10.13, for a total value of $202,600.00.
WebCytek's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 955.5M. Over the last four quarters, Cytek's revenue has grown by 176.8%. … little and cull soupsWebApr 11, 2024 · Cytek Biosciences Inc’s price-earnings (P/E) ratio is currently at 568.0, which is high compared to the Advanced Medical Equipment & Technology industry … little and davies financialWebFeb 28, 2024 · Cytek Biosciences, Inc. is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high … little and cuteWebFind the latest Earnings Report Date for Cytek Biosciences, Inc. Common Stock (CTKB) at Nasdaq.com. Cytek Biosciences, Inc. Common Stock (CTKB) Earnings Report Date … little and daviesWebFeb 28, 2024 · Cytek Biosciences, Inc. provided earnings guidance for the full year 2024. For the year, the company expects revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. little and easyWebApr 10, 2024 · Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of 100% and 6.64%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stoc... 4 months ago - Zacks Investment Research Cytek Biosciences Reports Third Quarter 2024 Financial Results little and davies victoria bcWebFeb 23, 2024 · Cytek Biosciences expects full year 2024 revenue to be in the range of $160 million to $168 million. Webcast Information. Cytek will host a conference call to discuss the fourth quarter 2024 financial results on Wednesday, February 23, 2024, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. A webcast of the conference call can be accessed at ... little and davies victoria